May 20, 2024

A Device That Zaps the Spinal Cord Gave Paralyzed People Better Control of Their Hands

(MIT Technology Review) – Reid received the device, called ARCex, as part of a 60-person clinical trial. She and the other participants completed two months of physical therapy, followed by two months of physical therapy combined with stimulation. The results, … Read More

May 16, 2024

Neuralink’s First Patient: ‘It Blows My Mind So Much’

(Bloomberg) – For the first time, Noland Arbaugh explains how Elon Musk’s brain implant, which allows him to control a computer with his thoughts, has changed his life. Noland Arbaugh still doesn’t quite know what happened. He doesn’t know many … Read More

May 15, 2024

As the FDA Evaluates Ecstasy Treatment for PTSD, Questions Mount About the Evidence

(NPR) – Clinical trials have inspired optimism in the drug for its potential to help the millions of Americans who experience PTSD. Accounts from some of those who’ve participated in the trials describe the treatment as transformational. But new and … Read More

May 14, 2024

New Articles from BMC Medical Ethics Are Now Available

BMC Medical Ethics has new articles available online. Articles include: “Research Ethics and Artificial Intelligence for global Health: Perspectives from the global forum on Bioethics in Research” by James Shaw, et al. “Physicians’ Views on the Role of Relatives in … Read More

May 9, 2024

Neuralink’s First Brain-Chip Implant in a Human Appeared Flawless. There Was a Problem.

(Wall Street Journal) – Neuralink encountered a problem with the implant in its first human patient, Noland Arbaugh, that reduced the amount of data it could capture from his brain, according to a blog post the company published on Wednesday. … Read More

May 8, 2024

Google DeepMind Unveils Next Generation of Drug Discovery AI Model

(Reuters via Yahoo!) – Google Deepmind has unveiled the third major version of its “AlphaFold” artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the company made a significant advance in molecular biology … Read More